Business ❯ Finance

Pharmaceutical Industry

Stock Market Market Trends Drug Pricing Drug Manufacturers Drug Development Company Performance Market Competition Market Reactions Market Dynamics Clinical Trials Stock Market Performance Sarepta Therapeutics Sun Pharmaceutical Industries Company Earnings Pharmaceutical Stocks Drug Costs Drug Licensing Corporate Governance Vaccine Development Mergers and Acquisitions Pricing Strategies Company News Corporate Restructuring Market Impact Pharmaceutical Companies Drug Trials Indian Pharma Exporters Manufacturing Market Protection Financial Reporting Stock Performance Drug Approvals Lobbying Market Practices Drug Companies Research and Development Packaging Industry

Pfizer CFO Dave Denton to Exit and Cecile Guegan Named Interim

The change raises investor concern about near-term guidance and succession as Pfizer integrates recent acquisitions and prepares to enter the obesity drug market.

FDA Grants Accelerated Approval to Kresladi, First Gene Therapy for Severe Pediatric LAD-1

EU Seals Provisional Overhaul of Drug Rules to Speed Access and Spur Innovation

Sarepta Shares Plunge After ESSENCE Phase 3 Miss in Duchenne Trial

Pfizer–Trump Drug-Pricing Deal and ‘TrumpRx’ Plan Jolt Health-Care Stocks Higher

Rapport Seizure Drug Posts Strong Phase 2 Signal as Company Plans Phase 3

Vertex Halts VX-993 Acute Pain Program After Phase 2 Trial Failure